Ehsan Bahrami

718 total citations
18 papers, 102 citations indexed

About

Ehsan Bahrami is a scholar working on Epidemiology, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Ehsan Bahrami has authored 18 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Molecular Biology and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Ehsan Bahrami's work include Liver Disease Diagnosis and Treatment (3 papers), Regulation of Appetite and Obesity (3 papers) and Acute Myeloid Leukemia Research (2 papers). Ehsan Bahrami is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Regulation of Appetite and Obesity (3 papers) and Acute Myeloid Leukemia Research (2 papers). Ehsan Bahrami collaborates with scholars based in Iran, Germany and United Kingdom. Ehsan Bahrami's co-authors include Sayyed Hamid Zarkesh‐Esfahani, Richard Ross, Masoud Etemadifar, Waleed Al–Herz, Daniel Kotlarz, Maximilian Witzel, Alireza Minagar, Hans‐Peter Horny, Michael H. Albert and Ahmad Chitsaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Ehsan Bahrami

14 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Bahrami Iran 6 27 26 26 21 18 18 102
Jason Chun Lao Australia 3 28 1.0× 20 0.8× 71 2.7× 9 0.4× 8 0.4× 4 145
Melanie Bull United Kingdom 5 49 1.8× 11 0.4× 83 3.2× 11 0.5× 5 0.3× 7 156
Guilherme Silva Julian Brazil 6 40 1.5× 13 0.5× 5 0.2× 13 0.6× 7 0.4× 32 157
Elsie M. Allen United States 8 53 2.0× 22 0.8× 68 2.6× 6 0.3× 30 1.7× 12 330
Lotte Geys Belgium 6 23 0.9× 29 1.1× 7 0.3× 5 0.2× 7 0.4× 11 93
Beata Samelko United States 6 33 1.2× 6 0.2× 13 0.5× 5 0.2× 11 0.6× 6 104
Jui-Cheng Tseng Taiwan 6 14 0.5× 10 0.4× 13 0.5× 5 0.2× 11 0.6× 7 90
Janusz Strzelczyk Poland 6 23 0.9× 34 1.3× 12 0.5× 19 0.9× 12 0.7× 21 128
Satoru Senoo Japan 10 27 1.0× 15 0.6× 35 1.3× 9 0.4× 6 0.3× 19 175
Amalia Pérez‐Gil Spain 8 30 1.1× 20 0.8× 88 3.4× 23 1.1× 8 0.4× 16 190

Countries citing papers authored by Ehsan Bahrami

Since Specialization
Citations

This map shows the geographic impact of Ehsan Bahrami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Bahrami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Bahrami more than expected).

Fields of papers citing papers by Ehsan Bahrami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Bahrami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Bahrami. The network helps show where Ehsan Bahrami may publish in the future.

Co-authorship network of co-authors of Ehsan Bahrami

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Bahrami. A scholar is included among the top collaborators of Ehsan Bahrami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Bahrami. Ehsan Bahrami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Steixner-Kumar, Agnes A., Diana Santacruz, Tobias Geiger, et al.. (2025). Single-cell landscape of peripheral immune cells in MASLD/MASH. Hepatology Communications. 9(5). 1 indexed citations
2.
Bahrami, Ehsan & M. Khodaei. (2025). Optimization of Cored Wire Arc Spraying of Amorphous FeCrNiSiWNbB Coating; Hot-Corrosion and High-Temperature Erosion Evaluations. Journal of Thermal Spray Technology. 34(4). 1368–1383. 1 indexed citations
3.
4.
Steixner-Kumar, Agnes A., Jörg F. Rippmann, Tanja Schönberger, et al.. (2024). Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells. Frontiers in Immunology. 15. 1232070–1232070. 6 indexed citations
5.
Bahrami, Ehsan, Tobias Geiger, Agnes A. Steixner-Kumar, et al.. (2023). An optimized protocol for isolation of hepatic leukocytes retrieved from murine and NASH liver biopsies. STAR Protocols. 4(4). 102597–102597. 2 indexed citations
6.
Bahrami, Ehsan, et al.. (2023). Cutaneous Adverse Drug Reactions: Regional Experience of a GlobalChallenge. Current Drug Safety. 19(1). 117–122.
7.
Vick, Binje, Karsten Spiekermann, Maja Rothenberg‐Thurley, et al.. (2022). WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice. Blood. 141(8). 955–960. 1 indexed citations
8.
Bahrami, Ehsan, Anna-Katharina Wirth, Rupert Öllinger, et al.. (2021). In Vivo CRISPR-Cas9 Screens in PDX Models Reveals ADAM10 As Novel Therapeutic Target in Acute Leukemia. Blood. 138(Supplement 1). 708–708.
9.
Bahrami, Ehsan, Anna-Katharina Wirth, Tobias Herold, et al.. (2019). A CRISPR/Cas9 Library Screen in Patients' Leukemia Cells In Vivo. Blood. 134(Supplement_1). 3945–3945. 2 indexed citations
10.
Bahrami, Ehsan, Maximilian Witzel, Tomáš Raček, et al.. (2017). Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations. Journal of Allergy and Clinical Immunology. 140(4). 1112–1119. 35 indexed citations
11.
Bahrami, Ehsan, Tomáš Raček, Maximilian Witzel, et al.. (2015). A Human Bone Marrow Failure Syndrome Caused By a Homozygous Mutation in MYSM1. Blood. 126(23). 1204–1204. 1 indexed citations
12.
Bahrami, Ehsan, Parisa Mirmoghtadaee, Gelayol Ardalan, et al.. (2014). Insulin and leptin levels in overweight and normal-weight Iranian adolescents: The CASPIAN-III study.. PubMed. 19(5). 387–90. 11 indexed citations
13.
Bahrami, Ehsan, et al.. (2014). Leptin hormone level in serum of opticospinal, neuromyelitisoptica and multiple sclerosis patients. Clinical and Experimental Neuroimmunology. 5(1). 77–83. 6 indexed citations
14.
Behjati, Mohaddeseh, et al.. (2012). Double-chimera proteins to enhance recruitment of endothelial cells and their progenitor cells. International Journal of Cardiology. 167(4). 1560–1569. 2 indexed citations
15.
Zarkesh‐Esfahani, Sayyed Hamid, et al.. (2011). Restricted leptin antagonism as a therapeutic approach to treatment of autoimmune diseases. HORMONES. 10(1). 16–26. 22 indexed citations
16.
Etemadifar, Masoud, Ahmad Chitsaz, Omid Behnamfar, et al.. (2011). Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis. Clinical Neurology and Neurosurgery. 114(1). 17–20. 11 indexed citations
17.
Zarkesh‐Esfahani, Sayyed Hamid, et al.. (2011). Leptin serum levels in different subtypes of Multiple sclerosis: does leptin play a role in progress of Multiple sclerosis? (44.9). The Journal of Immunology. 186(1_Supplement). 44.9–44.9. 1 indexed citations
18.
Zarkesh‐Esfahani, Sayyed Hamid, et al.. (2010). The Role of Infectious Agents in Etiology of Multiple Sclerosis. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026